Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS | 15 | 22 | -2,94 % | ||
| BIONTECH | 6 | 13 | -0,44 % | ||
| MEDPACE | 6 | - | +2,20 % | ||
| TRAVERE THERAPEUTICS | 5 | 11 | +2,86 % | ||
| COMPASS PATHWAYS | 4 | 11 | +6,37 % | ||
| TERNS PHARMACEUTICALS | 4 | 2 | -0,80 % | ||
| HUMACYTE | 4 | 4 | -0,15 % | ||
| DEFINIUM THERAPEUTICS | 3 | - | -4,02 % | ||
| DYNE THERAPEUTICS | 3 | - | -1,80 % | ||
| HARMONY BIOSCIENCES | 2 | 17 | -3,21 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 20:06 | Compass Pathways stock gets Morgan Stanley overweight rating on FDA voucher | 1 | Investing.com | ||
| 19:54 | Humacyte regains ex-U.S. rights to Symvess from Fresenius Medical Care | 3 | Seeking Alpha | ||
| 19:34 | ADMA vs Takeda: Which Plasma Therapy Stock Is the Better Buy Today? | 2 | Zacks | ||
| 19:34 | Tempus AI Nears Profitability as Operating Leverage Emerges | 2 | Zacks | ||
| 19:22 | The Fine Print In Trump's Most-Favored-Nation Drug Price Deal With Regeneron | 2 | The Deep Dive | ||
| 18:46 | Sanofi MS drug rejected in US gets an endorsement in Europe | 4 | BioPharma Dive | ||
| 18:18 | Regeneron Strikes Deal With Trump Administration To Cut Drug Prices | 2 | Benzinga.com | ||
| 18:10 | Sanofi gains long-awaited win for tolebrutinib as EU regulator endorses MS drug for approval | 3 | FiercePharma | ||
| 17:48 | Weekly Buzz: Sanofi, Regeneron Pharmaceuticals Get FDA Nod; It's A No For AbbVie, Grace Therapeutics; Eli Lilly Acquires Kelonia | 334 | AFX News | NEW BRUNSWICK (dpa-AFX) - This week's biotech landscape witnessed regulatory approvals across the U.S. and Europe, alongside FDA rejections, acquisitions, and positive data readouts spanning... ► Artikel lesen | |
| 17:30 | ANALYSE: Biontech: Was große Adressen vor dem Wochenende bereits wissen - Was Sie jetzt noch wissen müssen | Hebelschein-Spekulant | |||
| 17:24 | Sanofi, Arrowhead, Novartis among winners of EU recommendations this week | 7 | Seeking Alpha | ||
| 17:10 | Travere's launchpad positions Filspari for fast rise toward blockbuster sales: analyst | 1 | FiercePharma | ||
| 17:06 | Compass Pathways shares rise as FDA grants rolling review for depression drug | 2 | Investing.com | ||
| 17:00 | COMPASS Pathways psilocybin asset for depression awarded Commissioner voucher | 2 | Seeking Alpha | ||
| 16:42 | Compass Pathfinder Limited: Compass Pathways Announces FDA Granted NDA Rolling Review Request and Awarded Commissioner's National Priority Voucher | 230 | Business Wire | Compass is the most advanced company in classic psychedelics and has generated positive data from two ongoing large, well controlled Phase 3 clinical trials, designed to uphold the highest regulatory... ► Artikel lesen | |
| 16:38 | Eilmeldung am Abend: BIONTECH SE ADR wankt - jetzt handeln? | 5 | Maximilian Berger | ||
| 16:29 | Shandong Wit Dyne Health Co.,Ltd. Q1 Profit Falls | - | RTTNews | ||
| 16:18 | BMO cuts Medpace stock price target on cancellation concerns | 1 | Investing.com | ||
| 16:06 | Piper Sandler reiterates Regeneron stock rating on anti-VEGF shift | 3 | Investing.com | ||
| 15:46 | Regulatory round-up: Novartis, Sanofi and Arrowhead secure CHMP blessings | 3 | Pharmaceutical Technology |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.